Sandel Henry D, Day Terry, Richardson Mary S, Scarlett Matthew, Gutman Katharine A
Department of Otolaryngology, Head and Neck Surgery, Georgetown University Hospital, Washington, DC 20007, USA.
Laryngoscope. 2006 May;116(5):791-5. doi: 10.1097/01.mlg.0000208615.93883.b2.
The objective of this retrospective study and literature review was to compare the clinical and histologic criteria including tumor size and depth of invasion with outcomes in patients with Merkel cell carcinoma.
The state cancer registry provided patients (n = 46) diagnosed with Merkel cell carcinoma from 1992 through 2002. Pathology slides were reviewed by the author for tumor size, depth of invasion, Clark level, and margin status. Further clinical information and survival data were gathered from patient records. Statistical analysis was performed using t tests and Kaplan-Meier survival curves. Patients were excluded from specific analysis based on misdiagnosis, unavailability of pathology slides, absent medical records, or those lost to follow up.
Disease-free survival rates were 52%, 39%, and 9% at 1, 2, and 5 years, respectively. The average disease-free interval was 18.4 months (range, 1-80 months). No correlation was found between tumor size (P = .49), depth (P = .41), or Clark level (P = .82) to overall survival. A trend was found comparing tumor size or depth of invasion with local recurrence (P = .07) but with no correlation to regional recurrence (P = .93 and P = .60) or distant metastasis (P = .16 and P = .24). Overall recurrence was found in 60.7% of patients with local recurrence occurring in 18.1%, regional recurrence 40.9%, and distant recurrence 47.8%. Comparing patients with positive versus negative margins at initial excision, local recurrence was found in 33.3% versus 9.09% (P = .19), regional recurrence 66.6% versus 27.2% (P = .08), and distant metastasis 66.6% versus 45.4% (P = .36), respectively.
No correlation was found between tumor size or depth of invasion to patient survival or metastasis. However, there was a trend toward increased local and regional recurrence rates when comparing size and depth and in specimens with positive tumor margins. These outcomes are consistent with those reported in recent literature and further characterize the unpredictable nature of this disease. An aggressive approach should be taken, including wide local excision with negative tumor margins and lymph node dissection; however, larger multistate reviews are needed for additional support.
本回顾性研究及文献综述的目的是比较包括肿瘤大小和浸润深度在内的临床及组织学标准与默克尔细胞癌患者的预后情况。
州癌症登记处提供了1992年至2002年期间诊断为默克尔细胞癌的患者(n = 46)。作者复查病理切片以确定肿瘤大小、浸润深度、克拉克分级及切缘情况。从患者记录中收集进一步的临床信息和生存数据。使用t检验和卡普兰 - 迈耶生存曲线进行统计分析。基于误诊、病理切片无法获取、病历缺失或失访等情况,将患者排除在特定分析之外。
1年、2年和5年的无病生存率分别为52%、39%和9%。平均无病间期为18.4个月(范围1 - 80个月)。未发现肿瘤大小(P = 0.49)、深度(P = 0.41)或克拉克分级(P = 0.82)与总生存之间存在相关性。比较肿瘤大小或浸润深度与局部复发时发现有趋势(P = 0.07),但与区域复发(P = 0.93和P = 0.60)或远处转移(P = 0.16和P = 0.24)无相关性。60.7%的患者出现总体复发,其中局部复发占18.1%,区域复发占40.9%,远处复发占47.8%。比较初次切除时切缘阳性与阴性的患者,局部复发分别为33.3%和9.09%(P = 0.19),区域复发分别为66.6%和27.2%(P = 0.08),远处转移分别为66.6%和45.4%(P = 0.36)。
未发现肿瘤大小或浸润深度与患者生存或转移之间存在相关性。然而,比较大小和深度以及切缘阳性的标本时,局部和区域复发率有升高趋势。这些结果与近期文献报道一致,进一步表明了该疾病不可预测的性质。应采取积极的治疗方法,包括切缘阴性的广泛局部切除和淋巴结清扫;然而,需要更大规模的多州研究以提供更多支持。